BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16530619)

  • 21. Persisting Racial Disparities in Colonoscopy Screening of Persons with a Family History of Colorectal Cancer.
    Tsai MH; Xirasagar S; de Groen PC
    J Racial Ethn Health Disparities; 2018 Aug; 5(4):737-746. PubMed ID: 28812255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer screening among African Americans: the importance of physician recommendation.
    Taylor V; Lessler D; Mertens K; Tu SP; Hart A; Chan N; Shu J; Thompson B
    J Natl Med Assoc; 2003 Sep; 95(9):806-12. PubMed ID: 14527047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
    Seeff LC; Shapiro JA; Nadel MR
    J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early initiation of colorectal cancer screening in individuals with affected first-degree relatives.
    Murff HJ; Peterson NB; Greevy RA; Shrubsole MJ; Zheng W
    J Gen Intern Med; 2007 Jan; 22(1):121-6. PubMed ID: 17351851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. United States colorectal cancer screening practices among American Indians/Alaska Natives, blacks, and non-Hispanic whites in the new millennium (2001 to 2010).
    Johnson-Jennings MD; Tarraf W; Xavier Hill K; González HM
    Cancer; 2014 Oct; 120(20):3192-299. PubMed ID: 25123695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparities in colorectal cancer screening: a guideline-based analysis of adherence.
    James TM; Greiner KA; Ellerbeck EF; Feng C; Ahluwalia JS
    Ethn Dis; 2006; 16(1):228-33. PubMed ID: 16599375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Options for screening for colorectal cancer.
    Atkin W
    Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans.
    Walsh JM; Kaplan CP; Nguyen B; Gildengorin G; McPhee SJ; Pérez-Stable EJ
    J Gen Intern Med; 2004 Feb; 19(2):156-66. PubMed ID: 15009795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic variation of racial/ethnic disparities in colorectal cancer testing among medicare enrollees.
    Semrad TJ; Tancredi DJ; Baldwin LM; Green P; Fenton JJ
    Cancer; 2011 Apr; 117(8):1755-63. PubMed ID: 21472723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer test use among Californians of Mexican origin: influence of language barriers.
    Johnson-Kozlow M; Roussos S; Rovniak L; Hovell M
    Ethn Dis; 2009; 19(3):315-22. PubMed ID: 19769015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening colonoscopy versus sigmoidoscopy: implications of a negative examination for cancer prevention and racial disparities in average-risk patients.
    Wu BU; Longstreth GF; Ngor EW
    Gastrointest Endosc; 2014 Nov; 80(5):852-61.e1-2. PubMed ID: 24814774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.
    Shapiro JA; Klabunde CN; Thompson TD; Nadel MR; Seeff LC; White A
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):895-904. PubMed ID: 22490320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vital signs: colorectal cancer screening test use--United States, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(44):881-8. PubMed ID: 24196665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.